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Abstract 
 
Purpose: Coupling in a single device the potential for bone regeneration and the ability for 
in situ controlled drug release is a challenging field of research in bone tissue engineering; 
in an attempt to pursue this aim, membranes of mesoporous bioactive glass (MBG) 
belonging to the SiO2-P2O5-CaO ternary system were produced and characterized.  
Materials and methods: The glass was synthesized via a sol-gel route coupled with 
evaporation-induced self-assembly process by using a non-ionic block co-polymer as a 
mesostructure former. MBG structure and morphology, as well as mesopores size and 
shape, were investigated by X-ray diffraction, transmission electron microscopy and N2 
adsorption-desorption measurements. In vitro bioactivity was investigated by soaking MBG 
membranes in simulated body fluid (SBF) for different time frames. Ibuprofen was 
encapsulated into MBG pores and the drug release kinetics in SBF were assessed. 
Biological tests by using SAOS-2 cells were performed to evaluate the material 
cytocompatibility.  
Results: The material exhibited a high ability of inducing hydroxyapatite formation on its 
surface (bioactivity). Drug release kinetics in SBF are very similar to those obtained for 
mesoporous silica having mesopores size comparable to that of the prepared MBG (5 
nm). No evidence of cells viability depression was detected during in vitro culture, which 
demonstrates the good biological compatibility of the material.  
Conclusions: The easiness of tailoring and shaping, the highly bioactive and biocompatible 
behaviour and the drug uptake/release ability of the prepared materials can suggest their 
use as “smart” multifunctional grafts for bone reconstructive surgery. 
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INTRODUCTION 
 
Mesostructured materials belong to the class of nanomaterials, whose properties can be 
tailored at the nanometrical scale. Specifically, according to IUPAC classification 
mesoporous solids are characterized by pores ranging within 2-50 nm (1). These materials 
are generally obtained by coupling a sol-gel method, that is very effective to prepare 
glasses and ceramics at room temperature, with a supramolecular self-assembling 
process (2). This particular approach is possible by taking advantage of 
hydrophobic/hydrophilic features of some molecules, i.e. surfactants, to prepare 
supramolecular aggregates, called micellae (3). 
The first successful synthesis of ordered mesostructured silicas (OMSs) was reported in 
the early 1990s, when researchers of Mobil Oil Corporation used surfactants as structure-
directing agents (SDAs) (4). Since then, a wide range of OMSs, such as the hexagonal 
phases MCM-41 and SBA-15, have been prepared and investigated (4,5).  
The skill to tailor the channels size depending on the synthesis conditions, and the ordered 
pores structure of OMSs make these materials promising matrices for the encapsulation of 
functional molecules, such as dyes, drugs or enzymes. In particular, OMSs have attracted 
increasing interest in biomaterials science as devices for controlled drug release (6). For 
this purpose, recent studies have proposed composite hierarchical systems, coupling silica 
mesophases and bioactive scaffolds, in order to obtain multifunctional devices able to 
combine bone-bonding properties with drug delivery ability (7-10).  
As regards the applications in bone tissue engineering, it should be taken into account that 
as-such OMSs are not very suitable as bone fillers due their lack of bioactivity, that 
nevertheless can be opportunely induced. In fact, MCM-41 exhibited a good bioactive 
behaviour when its walls were doped with phosphorus (11) or by adding small quantities of 
bioactive glasses (12). Composite systems formed by MCM-41 and bioactive glass-
  
4 
 
ceramic scaffolds, necessary to guarantee implant bioactivity, have been also recently 
proposed for bone tissue engineering (7-10). 
The materials traditionally used for bone replacement, e.g. natural or synthetic 
hydroxyapatite (HA) (13), calcium phosphates (14) and bioactive glasses and glass-
ceramics (BGs and BGCs) (15,16), which have been widely investigated since the early 
1970s, are able to chemically bond to living bone without the formation of scar or fibrous 
tissue around the implant owing to the growth of a bone-like apatite layer on their surface 
in the course of the so-called “bioactivity process” (17). In particular, BGs are glasses of 
complex composition containing modifier oxides, e.g. CaO, Na2O and K2O, that locally 
interrupt the SiO2-based network. The bioactivity process is due to ion-exchange 
phenomena between the glass, which usually releases alkaline ions (Ca2+, Na+, K+), and 
the solution or the biological fluids put into contact with the implant. 
It is known that the formation of an apatite layer on sol-gel glasses surface is related both 
to the structure and to the composition of the material, whereas BGs obtained via 
traditional melting routes show a direct dependence only from the composition (18). In fact, 
it was demonstrated that an increase of the specific surface area and pores volume in sol-
gel BGs highly accelerates the HA formation kinetics, thereby enhancing the bone-bonding 
ability of the material (19,20). Recently, ordered SiO2-based mesoporous bioactive glasses 
(MBGs) have been synthesized through a combination between supramolecular chemistry 
and sol-gel process (21-23). The potential carried by this new class of biomaterials is 
remarkable, and, for instance, the use of MBGs as drug release systems (21,22), bone 
fillers (23) and components of glass cements inducing accelerated in vitro apatite 
formation (24) have been proposed.  
In the present work, a MBG belonging to the SiO2-P2O5-CaO ternary system has been 
synthesized in different forms (powders and membranes of adjustable thickness) and its 
features were investigated in detail by means of structural and morphological analysis, in 
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vitro bioactivity tests and biological compatibility assay. In addition, the drug uptake and 
release ability of the material was evaluated by using ibuprofen as a model drug. The great 
potential of the prepared MBG as a multifunctional material able to couple bone 
regeneration ability, in virtue of its excellent bioactivity, with drug release properties was 
particularly highlighted. In addition, the easiness and versatility of shaping the MBG in form 
of membranes could carry valuable advantages also from a surgical viewpoint, in an 
attempt to design and manufacture patient-designed bone grafts. In such a context, an 
ever better synergy between surgeons and materials scientists will be very desirable and 
appreciated. 
 
MATERIALS AND METHODS 
 
Materials synthesis 
 
In this work, a glass with ordered mesostructure was produced by coupling a traditional 
sol-gel method with the evaporation-induced self-assembly (EISA) process (25), following 
the procedure previously reported by Yan et al. (26). An amphiphilic triblock copolymer 
with sequence poly(ethylene glycole)-poly(propylene glycole)-poly(ethylene glycole) (PEG-
PPG-PEG), commercially called Pluronic 123 (P123), was used as a structure directing 
agent (SDA) (5). Briefly, 2.0 g of P123 (Mw = 5800 Da; Aldrich) were dissolved in 60.0 g of 
ethanol (99.5%, Sigma-Aldrich) and 1.0 g of 0.5 M HCl. After continuous magnetic stirring 
(~400 rpm) at 35 °C for 1 h, till P123 is completely dissolved, the glass oxides precursors, 
i.e. 6.7 g of tetraethyl orthosilicate (TEOS; 98.0%, Sigma-Aldrich), 0.73 g of triethyl 
phosphate (TEP; 99.8%, Sigma-Aldrich) and 1.4 g of calcium nitrate, Ca(NO3)24H2O 
(Sigma-Aldrich) (molar ratio Si/Ca/P = 80:15:5), were added to the synthesis batch (pH < 
1.0). The batch was continuously stirred at 35 °C for 24 h; then, the sol was cast into glass 
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moulds to undergo the EISA process at room temperature (RT). The gelation occurred 
after ~36 h; after 7 days of ageing, the dried gels were carefully removed from the moulds 
as transparent membranes and finally calcined at 700 °C in air for 5 h (heating rate and 
cooling rate set at 1 and 10 °C∙min-1 respectively). The steps involved in the preparation 
method of MBGs are resumed in Figure 1. 
 
 
Fig. 1 - Flow-chart of the procedure followed for manufacturing the mesoporous glass. 
 
Materials characterization 
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The MBG was investigated by means of wide-angle (2θ within 10-70°) and low-angle (2θ 
within 0.8-4°) X-ray diffraction (XRD, X’Pert Philips diffractometer with Bragg-Brentano 
camera, Cu anode and K radiation); specifically, the latter one was necessary to assess 
the mesostructure symmetry.  
Compositional investigations on the samples before and after calcination were carried out 
by energy dispersive spectroscopy (EDS; Philips Edax 9100); the samples were silver-
coated before analysis. 
Nitrogen (N2) adsorption-desorption porosimetry measurements at 77 K (Quantachrome 
Autosorb1) were carried out on the MBG ground in powders; in particular, the specific 
surface area (SSA) was assessed by using the Brunauer-Emmet-Teller (BET) method 
(27), whereas the pores size distribution was determined from the desorption branch of the 
isotherm through the Broekhoff-de Boer (BdB) method (28) and the BJH method (27). 
The structure and morphology of mesoporous channels were investigated in detail by 
means of transmission electron microscopy (TEM, Jeol JEM 3010 UHR operating at 300 
kV). 
In vitro bioactivity assessment involved the soaking of MBG membranes in 30 ml of 
acellular simulated body fluid (SBF) prepared according to the protocol proposed by 
Kokubo and co-workers (29). The different time frames chosen for the analysis were 8, 24, 
48 h and 7 days, in order to evaluate the formation of HA on samples surface also during 
the first hours of immersion. The solution was replaced twice a week to simulate fluid 
circulation in the human body; pH variations were daily monitored. 
 
Drug uptake and release 
 
The drug loading/release ability of the MBGs was tested by using ibuprofen, that has been 
used as a model drug in previous works (7-10). The absorption of ibuprofen (99.9% purity, 
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Sigma-Aldrich) was carried out by putting into contact a solution (9 ml) of ibuprofen in 
pentane (33 mg·ml-1, 0.16 M) with MBG powders for 24 h under continuous stirring. The 
drug uptake ability was evaluated by UV-visible spectrophotometry (Cary 500 Scan UV-vis 
spectrophotometer); specifically, the amount of ibuprofen absorbed by the sample was 
calculated from the difference in the concentration of drug in solution before and after 
contact with the sample, on the basis of the absorption at 263 nm, typical for ibuprofen 
molecules. Before analysis, the samples were centrifuged to avoid scattering effect due to 
MBG powders suspended in the solution. The test conditions were properly set in order to 
allow the application of Lambert-Beer’s law. A calibration curve was empirically derived by 
using solutions of ibuprofen in pentane of known concentrations. 
The drug release kinetics were evaluated in vitro by soaking the MBG powders in 30 ml of 
stirred SBF maintained at 37 °C. At different time frames – from 1 h up to 72 h after 
experiment beginning – a small amount of SBF (1 ml) was picked-up and analyzed 
through UV-visible spectrophotometry to assess the molecule concentration in the 
solution. A calibration curve was calculated by using solutions of ibuprofen in SBF of 
known concentrations, as well as we made for uptake tests. Before spectrophotometric 
analysis the samples were centrifuged for eliminating possible scattering errors due to the 
presence of residual glass powders in the analyzed solution. 
 
Biological tests 
 
MBG ground in powders was used for cells biocompatibility assay. The cells were not 
seeded directly on the material but a transwell-based method was adopted (30). Viability of 
cells was quantified by evaluating their mitochondrial activity; possible effects of dose-
dependence were also investigated by using different amounts of MBG powders (0.5, 1.0, 
1.5, 2.0 and 3.0 mg). The incubation time was set at 24 h for all the tests.  
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Human osteosarcoma cell line SAOS-2, obtained from the American Type Culture 
Collection (HTB85; ATCC), was used for the test. The cells were cultured in McCoy’s 5A 
modified medium with 1.5 mM L-glutamine and 25 mM HEPES (Cambrex Bio Science, 
Baltimore, MD), supplemented with 15% foetal bovine serum, 1 mM sodium pyruvate, 100 
IU/ml penicillin, 100 mg/ml streptomycin, 10-8 M dexamethasone and 10 mM β-
glycerophosphate (Sigma-Aldrich, Milwaukee, WI); 2.84 mM ascorbic acid, another 
osteogenic supplement, was present as a component of McCoy’s 5A modified medium. 
The cells were cultured at 37 °C with 5% CO2, routinely trypsinized after reaching 
confluence conditions, counted and finally seeded onto the culture wells. 
MBG powders were sterilized by autoclave treatment (120 °C for 20 min at 1 atm) before 
cytotoxicity test. The materials were applied to the base of the transwells (6.5 mm in 
diameter, pores size of 0.4 μm) (Costar Transwell-Clear, Corning Costa, Cambridge, MA). 
To compare the relative toxicities of different materials, the transwells were transferred into 
24-well culture plates that were seeded with cells (2.5×105 cells/well) for 24 h before the 
respective powders were transferred to the transwells. The control group (CTRL) was 
represented by the cases in which powders were not transferred to the culture wells. The 
tests were performed on triplicate samples.  
To evaluate the mitochondrial activity of the seeded cells, i.e. the viability of SAOS-2 cells 
during the culture period, a test with 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) (Sigma-Aldrich) was performed after incubation for 24 h. The culture 
medium was replaced by a 0.5 mg/ml solution of MTT in phosphate-buffered saline (PBS) 
(137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH = 7.4) and the cells 
cultures were incubated for 4 h. The test is based on the fact that viable cells can reduce 
MTT into formazan crystals: when reduced in a cell, either enzimatically or through direct 
reaction with NADH/NADPH, MTT turns to bright blue and forms a water-insoluble 
precipitate (formazan). After removing the MTT solution, 500 μl of dimethyl sulphoxide 
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(Sigma-Aldrich) were added to solubilize the formazan products and the well plate 
containing the cells was shaken for 20 min on a shaker. Aliquots of 200 μl were sampled 
and the related absorbance values were measured at 570 nm by a microplate reader 
(BioRad Laboratories, Hercules, CA). A standard curve of cell viability was used to 
express the results as percentage out of the total number of cells. 
 
RESULTS AND DISCUSSION 
 
Examples of as-synthesized MBG membranes are reported in Figures 2a,b. After the 
extraction from the mould, the transparent membranes, characterized by thickness ranging 
within 300-500 μm, can be easily cut in various shapes, and, for instance, disk-shaped 
(Figure 2a) or plug-shaped (Figure 2b) samples can be produced. The EDS spectrum of 
non-calcined membrane is reported in Figure 2c. It is possible to observe the peaks of 
silicon (Si), phosphorus (P) and calcium (Ca) due to glass oxides featuring material 
composition. In addition, an intense peak of carbon (C) is visible because the organic 
surfactant is still present inside the mesopores. The weak peak corresponding to chlorine 
(Cl) is due to Cl– ions, provided by HCl entrapped in the glass structure. The presence of 
the silver (Ag) peak in the EDS pattern is due to the metal coating necessary for analysis. 
Examples of MBG membranes obtained after calcination are shown in Figures 3a,b. 
During calcination, the surfactant (P123) burns-out and the consolidation of the 
mesostructure is promoted: as known, in this phase the pores walls become thicker and 
the pores size decreases. The resulting calcined samples are brittle, semitransparent 
membranes of SiO2-P2O5-CaO glass, that maintain their original shape imparted before 
calcination. As foreseen, the calcined MBG membranes are thinner (thickness ranging 
within 100-300 μm) than the as-synthesized ones; the thickness reduction is due to the 
shrinkage that occurs during calcination. A very weak peak of carbon (C) is distinguishable 
  
11 
 
in the EDS pattern (Figure 3c), which demonstrates that the organic surfactant was almost 
totally removed. Thermogravimetrical analyses (Mettler Toledo TGA/SDTA 851, range of 
analysis 25-1000 °C, heating rate 20 °C·min-1; software: STARe 6.10) were also 
performed (data not reported) to quantitatively assess the residue of surfactant and, 
therefore, to estimate the effectiveness of calcination. Specifically, the residual organic 
fraction that remained entrapped inside the pores was estimated to be <5 %wt. of the 
initial weight of the sample.  
 
 
Fig. 2 - As-synthesized mesoporous membranes: (a) disk-shaped and (b) rectangle-
shaped (“plug”) samples; (c) EDS pattern. 
 
 
Fig. 3 - Calcined mesoporous membranes: (a) disk-shaped and (b) rectangle-shaped 
(“plug”) samples; (c) EDS pattern. 
 
It is worth to notice that the final thickness of the membranes can be easily tailored: in fact, 
the more the sol volume cast into the mould, the higher is the thickness of the resulting 
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MBG membrane. The linear shrinkage, roughly calculated on the basis of membranes 
thickness before and after calcination, ranged within 30-40%; this important point, related 
to MBG membranes design and tailoring, will be further discussed at the end of the 
following subsection.  
 
Structural analysis 
 
The wide-angle XRD pattern of calcined MBG is depicted in Figure 4. The presence of a 
broad halo between 2θ ≈ 15.0° and 2θ ≈ 35.0° demonstrates that the material is 
completely amorphous. 
Figure 5 collects low-angle XRD investigations on the MBG before and after calcination. 
The spectrum of as-synthesized MBG (Figure 5a) shows a unique weak peak at 2θ ≈ 
0.93°. The presence of this peak demonstrates that an ordered structure of mesopores 
already existed in the non-calcined material, but the peak intensity was weak as the 
surfactant (P123) filled the on-forming mesopores. After calcination, when the SDA is 
removed, the basal peak due to the mesophase order is clearly distinguishable at 2θ ≈ 
1.35° (Figure 5b), together with a broad scattering at higher angles (2θ ≈ 1.70°). 
The mesophase symmetry is a crucial point and was determined combining low-angle 
XRD results with TEM data that will presented in the following subsection. The structure of 
the prepared MBG was interpreted as a 2-D hexagonal symmetry, together with some 
disordered wormlike domains. 
By comparing the patterns shown in Figure 5, it can be observed that the position of the 
basal peak shifts towards a higher 2θ-value after calcination. This is due to the shrinkage 
of the material during calcination, i.e. the surfactant burning-out, which yields a decrease 
of the interplanar distance. 
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Fig. 4 - Wide-angle XRD pattern of the calcined MBG sample. 
 
 
Fig. 5 - Low-angle XRD spectra of the prepared MBG: (a) as-synthesized and (b) calcined 
sample. 
 
From XRD data it is also possible to give an evaluation – although rather rough – of the 
shrinkage due to calcination, which should be carefully taken into account for MBG 
membrane design and tailoring. Assuming the basal peak being the (1 0 0) reflection of the 
2-D hexagonal phase, then *100d = 9.40 nm and 100d = 6.50 nm are the interplanar distance 
of the non-calcined and calcined material, respectively. Hence, the cell parameters of the 
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mesophase before and after calcination are, respectively, *100
*
3
2
da   = 10.85 nm and 
100
3
2
da   = 7.50 nm. Eventually, the linear shrinkage linS (%) can be calculated as 
1001
*







a
a
Slin  = 29.1 %; this value is consistent with the range assessed qualitatively 
by comparing the thickness of the MBG membranes before and after calcination. Under 
the assumption that the cell parameter is the characteristic dimension of the mesophase, a 
rough evaluation of the volumetric shrinkage volS (%) can be finally obtained as 
 
1001
3*
3










a
a
Svol = 66.9 %.  
Knowing the shrinkage, the size of the mould and the volume of sol cast into the mould, it 
is possible – at least ideally – to design the shape and thickness of the final calcined MBG 
membrane, so that it can match the size and shape of patient’s bone defect.       
 
Mesopores characterization 
 
Figure 6 shows a typical IV type well-defined N2 sorption isotherm for calcined MBG 
ground in powders. The three relevant regions of the adsorption branch, typically 
corresponding to (i) monolayer/multilayer adsorption onto the mesopores surface, (ii) 
capillary condensation and (iii) multilayer adsorption onto the particles external surface, 
are clearly distinguishable. As described elsewhere, the shape of the hysteresis loop is 
tightly related to the shape of mesopores (31): in the present case, the MBG channels 
have a well defined cylindrical shape with a diameter of ~5.0 nm (BdB and BJH methods 
led to very close results, as reported in Table I). 
Figure 7a depicts a section along the direction parallel to channels axes, that reveals a 
highly ordered arrangements of 1-D open, cylindrical and parallel mesopores, as 
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previously inferred from N2 adsorption-desorption analysis. In Figure 7b the system of 
ordered parallel channels can be simultaneously seen both along the channels axes and 
orthogonally to them; the 2-D hexagonal symmetry of the ordered mesopores system is 
clearly distinguishable.  
 
 
Fig. 6 - N2 sorption isotherm of the MBGs calcined at 700 °C for 5 h. 
 
 
Fig. 7 - TEM images of the calcined MBGs. The hexagonal symmetry of the mesophase is 
emphasized, as an example, in two white circles. 
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Table I. TEXTURAL PARAMETERS OF THE MBG ASSESSED BY N2 ADSORPTION-DESORPTION 
MEASUREMENTS AND TEM ANALYSIS. 
Parameter Analysis Average value 
SSA [m2∙g-1] BET 450.0 
Pores size [nm] 
BdB/BJH 5.0 
TEM 4.9 
Pores wall thickness [nm] TEM 3.0 
 
The pores size calculated by means of N2 adsorption-desorption measurements is in good 
accordance with that assessed by TEM, as shown in Table I. In addition, the cell 
parameter calculated from TEM data (7.90 nm) is consistent with that determined by XRD 
analysis (7.50 nm). 
It should be noticed that the investigated MBG is not completely organized in ordered 
domains, but two different domains can be distinguished: (i) well-ordered regions 
according to a hexagonal symmetry and (ii) poorly ordered or disordered regions (wormlike 
domains).  
The importance of a structure constituted by totally or partially ordered channels of 
nanometrical size is relevant in a material to enhance its bioactivity. As previously 
discussed, the mesopores texture allows to increase the surface area (Table I) available 
for ion-exchange phenomena, thereby promoting the bioactivity process and the kinetics of 
HA formation.   
 
In vitro bioactivity tests 
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Figure 8 collects the SEM micrographs of MBG membrane surface after soaking for 8, 24, 
48 h and 7 days in SBF; the corresponding EDS spectra are also reported. After 8 h of 
immersion, globe-shaped agglomerates are already distinguishable on the MBG 
membrane (Figure 8a). The newly formed phase, whose formation is due to ion-exchange 
phenomena between the MBG and the solution, is apatite-like, as qualitatively assessed 
by the EDS spectrum reported in Figure 8b. An intense peak corresponding to silicon (Si) 
is clearly visible in the pattern and can be attributed to (i) the presence of a silica-gel layer, 
according to the bioactivity process proposed by Hench and co-workers (32,33) and/or (ii) 
a substrate effect due to the finite volume of EDS analysis (~1 μm3). The Si-peak becomes 
progressively weaker as the soaking time increases (Figures 8d and 8f) and it is no more 
visible after 7 days of soaking (Figure 8h). This demonstrates that the newly formed phase 
progressively grew in amount and thickness, and finally the typical “cauliflower” 
morphology of HA can be recognized after soaking for 7 days (Figure 8g)  
The quantitative EDS data reported in Table II show that the agglomerates visible on the 
membrane after 8 h of soaking in SBF can be identified as Ca-deficient HA (Ca/P = 1.51). 
The Ca content in the newly formed phase progressively rises as the soaking time 
increases; after 7 days, a molar Ca/P ratio of 1.67, corresponding to the stoichiometric 
Ca/P ratio of natural HA, was detected. 
The XRD pattern reported in Figure 9 shows, as expected, several marked peaks 
assignable to the (0 0 2), (2 1 1), (3 0 0), (2 0 2) and (2 1 3) reflections of HA. The main 
(double) peak at 2θ ≈ 32.0° is broad due to the microcrystalline nature of the HA nucleated 
on MBG surface. 
It is worth to underline that the prepared MBG membranes, although having a silica 
content of 80% mol., are highly bioactive. Hench and co-workers demonstrated that, for 
traditional melt-derived glasses, the silica content has to be 60 %mol. or less to allow to 
bond with bone (34). Nevertheless, bone bonding can be achieved for sol-gel glasses with 
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up to 90 %mol. of SiO2, due to their high surface area, typically within 100-200 m
2∙g-1 
(about two order of magnitude higher than that of melt-derived glasses) (35,36). 
 
 
Fig. 8 - Surface micrographs and corresponding compositional analyses of the MBG 
membranes after soaking in SBF for (a,b) 8 h; (c,d) 24 h; (e,f) 48 h; (g,h) 7 days. 
 
Table II. EDS ANALYSIS (SEMIQUANTITATIVE EVALUATION) ON THE SURFACE OF THE MBG 
MEMBRANES SOAKED IN SBF. 
Soaking time Ca/P (molar ratio) 
8 h 1.51 
24 h 1.58 
48 h 1.62 
7 days 1.67 
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Fig. 9 - XRD pattern of the MBGs after soaking for 7 days in SBF. 
 
The excellent bioactive properties observed for the prepared MBG membranes can be 
explained considering that the nanoporous texture of the material plays a key role in 
enhancing its surface area. In fact, the system of mesoporous channels enhances the 
surface area up to values still higher (Table I) than those exhibited by sol-gel glasses. 
Therefore, the ion-exchange phenomena between MBG and SBF in vitro or between MBG 
and the biological fluids in vivo can be remarkably promoted. The presence of an ordered 
mesostructure significantly affects the bioactive properties of the glass and, generally, has 
more influence than glass chemical composition in the HA nucleation stage during the 
bioactivity process (23).  
The pH variation in the solution, resulting from ion-exchanges with the material, is quite 
moderate (pH < 8.0; reference value for SBF = 7.40), thus no cytotoxic effect induced by 
the material, when implanted, is foreseen. 
 
Drug uptake and release ability 
 
The potential of mesoporous materials of acting as matrices for the encapsulation and 
subsequent release of drug molecules has been underlined in many research works, as 
the size of the mesopores can be designed to match, at least approximately, the sizes of a 
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wide range of biomolecules. Since the material synthesized in this work exhibited a very 
high bioactivity with fast kinetics of HA formation, it was very interesting to assess if such a 
property could negatively affect the drug release ability of the MBG. In fact, one might 
reasonably hypothesize that the HA agglomerates, formed during immersion in SBF, can 
obstruct the mesoporous channels, thereby inhibiting – or strongly depressing – the 
ibuprofen release from the material. 
The test of ibuprofen uptake was carried out in duplicate to have a control of the test 
repeatibility. Actually, the test was found to be highly repeatable, as the analyses on both 
samples led to analogous results. It was estimated that the material could absorb an 
ibuprofen amount equal to ~25 %wt. of its starting weight. This value is slightly higher than 
that obtained by Izquierdo-Barba et al. (37) who tested mesoporous materials belonging to 
the SBA-15 family characterized by mesopores size similar to that of the MBGs prepared 
in this work. The amount of ibuprofen absorbed by MBG powders was also found 
comparable to the data obtained testing mesophases with smaller pores, e.g. MCM-41 (8-
10), that should be expected to exhibit a higher affinity for ibuprofen molecules due to a 
better dimensional matching between drug molecule length and pore size. 
According to the uptake tests, also the ibuprofen release tests were performed in 
duplicate, and both of them led to similar results. Figure 10 shows the kinetics of ibuprofen 
delivery in SBF. Above 90% of the drug absorbed into the mesopores was released within 
the first two hours of soaking and, therefore, before HA formation occurred. Hence, HA 
growth and ibuprofen release followed quite separate kinetics and, specifically, the 
material bioactivity does not negatively interfere with the drug release ability of MBG. After 
the first 24 h of analysis, the percentage of released ibuprofen seems to decrease 
progressively (from 96% after 24 h up to 93% after 50 h); this phenomenon may be 
explained considering that the material, after releasing most of the absorbed drug, can re-
uptake a small amount of it. The release kinetics from the MBG are very similar to those 
  
21 
 
obtained by Izquierdo-Barba et al. testing SBA-15 spheres (37), that have mesopores size 
comparable to that of the prepared MBGs. 
 
Biological compatibility and cytotoxicity 
 
The mitochondrial activity of SAOS-2 cells was used as a reliable index for quantifying 
their viability. Figure 11 reports the results after cells incubation for 24 in response to 
different MBG amounts. Control sample (CTRL; medium only without MBG powders) 
exhibits a cells viability of ~90% (< 100%); this occurs because a cells fraction (~10% in 
the present case) is damaged by the intrinsic oxidative stress due to cells manipulation 
during test procedures. 
In comparison with CTRL, the presence of MBG powders did not seem to significantly 
affect cells viability, that remain very high (>75%) in all the experiments. Cells viability did 
not seem to be compromised by the presence of MBG; further tests for investigating the 
material effect after time frames longer than 24 h are currently in progress. From the data 
reported in Figure 11, a high MBG amount seems to emphasize cells viability (maximum 
viability was registered in presence of 3 g of MBG); however, it is not surprising as it is 
known that bioactive glasses can influence the cycle, metabolism and activity of cells (38). 
It should be considered that MBGs are highly reactive and, specifically, Si and Ca ions 
released from the glass can exert a gene control regulation emphasizing the activity of 
bone cells (39-41).  
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Fig. 10 - Ibuprofen release kinetics from MBG powders in SBF.  
 
 
Fig. 11 - Viability of SAOS-2 cells after incubation for 24 h in presence of MBG powder by 
using the transwell culture method. 
 
CONCLUSIONS 
 
Mesoporous glass belonging to the SiO2-CaO-P2O5 ternary system was successfully 
synthesized in form of membranes with adjustable thickness in the 100-300 μm range. 
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After calcination, the glass exhibited an ordered structures of mesopores (pores size ~5 
nm) ascribable to hexagonal symmetry. The presence of an ordered texture of mesopores 
eventually resulted in excellent bioactive properties, as the pores contributed remarkably in 
increasing the specific surface area of the material (~450 m2·g-1), thereby enhancing the 
ion-exchange phenomena between glass and solution during immersion in SBF. This led 
to the fast formation (within 8 h) of a calcium-phosphate layer on the membrane surface; 
such a newly formed phase progressively crystallizes in HA, characterized by its typical 
globular “cauliflower” morphology. In addition, the mesoporous structure imparted to the 
material the ability of encapsulating ibuprofen molecules within its mesochannels. 
Ibuprofen release from MBG in SBF occurred with kinetics similar to that observed for pure 
silica mesophases with analogous pores size. Finally, the MBG exhibited an excellent cells 
tolerance, without negatively affecting SAOS-2 cells viability during in vitro tests.  
As a whole, the results suggest the potential use of the prepared MBG in bone tissue 
engineering as a bioactive drug release system suitable for bone defect fillers and 
controlled local drug therapy. 
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Figure legends 
 
Fig. 1. Flow-chart of the procedure followed for manufacturing the mesoporous glass.  
Fig. 2. As-synthesized mesoporous membranes: (a) disk-shaped and (b) rectangle-
shaped (“plug”) samples; (c) EDS pattern. 
Fig. 3. Calcined mesoporous membranes: (a) disk-shaped and (b) rectangle-shaped 
(“plug”) samples; (c) EDS pattern. 
Fig. 4. Wide-angle XRD pattern of the calcined MBG sample. 
Fig. 5. Low-angle XRD spectra of the prepared MBG: (a) as-synthesized and (b) calcined 
sample. 
Fig. 6. N2 sorption isotherm of the MBGs calcined at 700 °C for 5 h. 
Fig. 7. TEM images of the calcined MBGs. The hexagonal symmetry of the mesophase is 
emphasized, as an example, in two white circles. 
Fig. 8. Surface micrographs and corresponding compositional analyses of the MBG 
membranes after soaking in SBF for (a,b) 8 h; (c,d) 24 h; (e,f) 48 h; (g,h) 7 days. 
Fig. 9. XRD pattern of the MBGs after soaking for 7 days in SBF. 
Fig. 10. Ibuprofen release kinetics from MBG powders in SBF.  
Fig. 11. Viability of SAOS-2 cells after incubation for 24 h in presence of MBG powder by 
using the transwell culture method. 
 
 
 
 
 
 
 
